BioXcel Therapeutics (BTAI) Q4 loss widens on higher expenses
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) reported a wider net loss for the fourth quarter, owing to an increase in research and development expenses. Being a…
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) reported a wider net loss for the fourth quarter, owing to an increase in research and development expenses. Being a…
— Matinas BioPharma (NYSE: MTNB) reported loss of $0.04 per share in the fourth quarter of 2019, vs $0.03 per share loss expected. — Initiated ENHANCE-IT study…
— Thor Industries (NYSE: THO) reported Q2 2020 earnings of $0.52 per share, vs. $0.70 expected. — Sales grew 55% to $2 billion, vs. $1.82…
— Sogou Inc. (NYSE: SOGO) reported Q4 2019 earnings per ADS of $0.10 per share, vs. $0.08 expected. — Revenues rose 1% to $301 million,…
Dick’s Sporting Goods’ (NYSE: DKS) shares have fallen 30% since the beginning of this year. The stock is currently trading 30% below its 52-week high…
Cloudera Inc. (NYSE: CLDR) is slated to report its fourth-quarter 2020 earnings results on Tuesday, March 10, after the market closes. The enterprise data cloud…
Investors could rejoice as Micron Technology (NASDAQ: MU) stock has turned cheaper and undervalued. The shares are expected to head higher as the earnings results…
InspireMD (NYSE: NSPR) has incurred losses consistently over the past several years. Of late, shareholders have been apprehensive about their investments as things went from…
J.C. Penney’s (NYSE: JCP) shares have fallen 44% since the beginning of this year. The stock is trading 68% below its 52-week high of $1.92.…
Urban Outfitters’ (NASDAQ: URBN) stock suffered one of the biggest single-day losses this week after the lifestyle retail chain disappointed the market with weak fourth-quarter…